In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimiz...
IMMUNOVACCINE TECHNOLOGIES INC.
10 enregistrements totalisant 5,661,363.01 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $5,661,363 | 10 enregistrements |
Enregistrements
ImmunoVaccine Technologies Inc.
$2,655,429.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
ImmunoVaccine Technologies Inc.
$640,332.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
ImmunoVaccine Technologies Inc.
$636,596.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
This project aims to establish the clinical safety and immunogenicity of a vaccine candidate based on the Company’s DPX delivery technology and incorporating peptides targeting novel epitopes from the...
IMMUNOVACCINE TECHNOLOGIES INC.
$497,285.00
National Research Council Canada | Conseil national de recherches Canada
EF 2012-2013
Canada
IMMUNOVACCINE TECHNOLOGIES INC.
$443,478.01
National Research Council Canada | Conseil national de recherches Canada
EF 2012-2013
Canada
IMMUNOVACCINE TECHNOLOGIES INC.
$407,699.00
National Research Council Canada | Conseil national de recherches Canada
EF 2012-2013
Canada
IMMUNOVACCINE TECHNOLOGIES INC.
$260,148.00
National Research Council Canada | Conseil national de recherches Canada
EF 2009-2010
Canada
IMMUNOVACCINE TECHNOLOGIES INC.
$49,458.00
National Research Council Canada | Conseil national de recherches Canada
EF 2012-2013
Canada
IMMUNOVACCINE TECHNOLOGIES INC.
$45,938.00
National Research Council Canada | Conseil national de recherches Canada
EF 2009-2010
Canada
ImmunoVaccine Technologies Inc.
$25,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
This project will provide cyber security assistance to a priority covid response firm.